Friday 6 November 2026 Export RVTY’s income statement to Excel — free account

Revvity Inc.

RVTY Healthcare Diagnostics & Research

Revvity Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.9 billion, up 3.67% from fiscal 2024.

Revenue: +4.29%
EPS: +2.17%
Free cash flow: +27.0%
Total debt: −18.1%

Quarter to September 2026, against a year earlier

150.97 8.46 −5.31%

Follow RVTY

Alert me

Market cap: $16.8B
P/E: 71.9×
Fwd P/E: 66.2×
Dividend yield: 0.19%
F-score: 6/9
Altman Z: 2.49
Beneish M: −2.45
Dividend safety: 80/100

Overview Business Profile Earnings & Analysis Segments Valuation Filings

Revvity Inc. 10-Q filed Aug 6, 2024

Fiscal Q2 2024 · Period ended Jun 30, 2024 · Filed Aug 6, 2024 · accepted 4:09 PM ET · Document on sec.gov · Filing index

Nothing in this filing raised a red flag. The document itself is on sec.gov.

Read the filing on sec.gov